Promoter holding
64.27%
BC
Bayer Cropscience Limited - Due diligence report
A 360° intelligence report on Bayer India: trust score, financial health, credit view, compliance, directors, growth and distress signals - …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Bayer India — 360° Intelligence Report
Generated from MCA filings & public records71/100
Trust Score
Moderate
Bayer India is assessed as Moderate with a Trust Score of 71/100. Bayer India is an active public limited indian non-government company incorporated in 1958, operating in the Agriculture sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Bayer Cropscience Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
71/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
42/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
80/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Profitable - internal accruals available.
Charges position: 30 open (113.57 cr) · 21 satisfied (219.40 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Union Bank Of India | 13 | 48.0 cr |
| Central Bank Of India | 3 | 48.0 cr |
| Canaa Bank | 4 | 48.0 cr |
| Deutsche Bank | 1 | 48.0 cr |
| The Industrial Credit And Invest. Corp. Of Inida Limited | 3 | 48.0 cr |
| Societe Generale | 1 | 48.0 cr |
Compliance Score: 42/100 Caution Indicated
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BSE.
- Litigation present in 3 court forum(s).
- Delayed payments to MSME suppliers disclosed (37 disclosure(s)).
- 23 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 80/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| MANORAMA CHIVUKULA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SIMON THORSTEN WIEBUSCH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PANKAJ RAMANBHAI PATEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RADHIKA GOVIND RAJAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRIYA MURALI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Dr Miriam Holstein | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SIMON JOHANNES BRITSCH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJIV RANGRASS | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| THOMAS HOFFMANN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHARATI RATAN SHETTY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Vinit Rajesh Jindal | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Vinit Rajesh Jindal | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Jana Marlen Ackermann | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 13 directors on the board.
- No disqualified or deactivated DINs.
- 6 director exits in 3 years - high churn.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Bayer Vapi Private Limited
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 9 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Bayer Vapi Private Limited | Holding Company | 74.00% |
| Monsanto Investments India Private Limited | Holding Company | 74.00% |
| Bayer Sas | Holding Company | 74.00% |
| Bayer Cropscience Ag | Holding Company | 74.00% |
| Bayer Ag | Holding Company | 74.00% |
| Monsanto Company | Holding Company | 74.00% |
Key managerial personnel: SIMON THORSTEN WIEBUSCH (Managing Director) · SIMON JOHANNES BRITSCH (CFO) · Vinit Rajesh Jindal (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 65 · Distress 60
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Asset base grew 24% - capacity expansion.
Operating for 67+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Profit declined two years in a row.
Outside liabilities up 0.86 in a year.
4 director exits within 2 years.
Compliance score is weak (42/100).
30 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 2.83 cr.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence56/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment78/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 30 open charge(s) of 113.57 cr already registered.
- Compliance gaps should be priced into terms.
Investor view75/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events21 Aug 2025
Last AGM held
Annual general meeting
20 Aug 2025
Director ceased
SANJIV RANGRASS
01 Aug 2025
Director appointed
SANJIV RANGRASS (Director)
09 Apr 2025
Director appointed
Vinit Rajesh Jindal (Cfo)
01 Apr 2025
Director ceased
Jana Marlen Ackermann
31 Mar 2025
Latest balance sheet
Filed with ROC
01 Mar 2025
Director appointed
Vinit Rajesh Jindal (Whole-time director)
Director appointed
Jana Marlen Ackermann (Director)
Director ceased
Vinit Rajesh Jindal
13 Aug 2024
Director ceased
RADHIKA GOVIND RAJAN
12 Aug 2024
Director appointed
BHARATI RATAN SHETTY (Company Secretary)
23 Jul 2024
Director appointed
RADHIKA GOVIND RAJAN (Director)
31 May 2024
Director ceased
NIKUNJ JAYSUKHLAL SAVALIYA
24 Mar 2024
Director ceased
Dr Miriam Holstein
01 Feb 2024
Director appointed
Dr Miriam Holstein (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
13 active director(s) / partner(s); board looks stable and experienced.
23 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Tatachemicals | L24239MH1939PLC002893 | Mumbai, Maharashtra, India |
| Atul | L99999GJ1975PLC002859 | Ahmedabad, Gujarat, India |
| Lauruslabs | L24239AP2005PLC047518 | Anakapalle, Andhra Pradesh, India |
| Piramal Pharma | L24297MH2020PLC338592 | Mumbai, Maharashtra, India |
| Pcblltd | L23109WB1960PLC024602 | Kolkata, West Bengal, India |
| Alembic | L26100GJ1907PLC000033 | Baroda, Gujarat, India |
| Alembic Pharmaceuticals | L24230GJ2010PLC061123 | Vadodara, Gujarat, India |
| Supreme Petrochem | L23200MH1989PLC054633 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Bayer India before audits and certifications: compliance score 42/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Bayer India: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Bayer India - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 71/100, distress signals and MSME payment-delay disclosures - know whether Bayer India pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Bayer India - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Bayer India an active company?
Bayer India has MCA status “Active” with a compliance score of 42/100 (Caution Indicated).
Is Bayer India financially healthy?
Bayer India has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Bayer India?
Its overall Trust Score is 71/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Bayer India?
The ultimate holding entity is Bayer Vapi Private Limited. 13 active director(s) are on record.
Does Bayer India have loans or charges against its assets?
30 open charge(s) are registered against its assets, and 21 earlier charge(s) stand satisfied.
Is Bayer India up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 42/100 (Caution Indicated).
Is it risky to lend to Bayer India?
Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
